Canadian Pharmacy Blog

The FDA’s Psychopharmacologic Drugs Advisory Committee has voted not to recommend approval of modafinil tablets (Sparlon, Cephalon), an investi-gational medication for children and adolescents with ADHD. Cephalon had received an approvable letter from the FDA in October 2005. Modafinil was deemed effective for its intended use, but more safety data were needed. Sparlon is a [...]

A methylphenidate transdermal system (Daytrana, Shire) offers another option for children six to 12 years of age with Attention Deficit Hyperactivity Disorder (ADHD). This is the first non-oral medication for ADHD. The patch, in strengths of 10, 15, 20 and 30 mg, is designed to be worn during a child’s normal daily activities. It should [...]